Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death
Yujeong Moon, Man Kyu Shim, Jiwoong Choi, et al.
Theranostics (2022) Vol. 12, Iss. 5, pp. 1999-2014
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy
Yunrong Yang, Jia Huang, Min Liu, et al.
Advanced Science (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 132
Peptides as multifunctional players in cancer therapy
Sri Murugan Poongkavithai Vadevoo, Smriti Gurung, Hyun‐Su Lee, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 6, pp. 1099-1109
Open Access | Times Cited: 84
Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation
Hanhee Cho, Seong Ik Jeon, Cheol‐Hee Ahn, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 728-728
Open Access | Times Cited: 69
Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics
Harshita Tiwari, Nilesh Rai, Swati Singh, et al.
Bioengineering (2023) Vol. 10, Iss. 7, pp. 760-760
Open Access | Times Cited: 69
Multifunctional Self-Assembled Peptide Hydrogels for Biomedical Applications
Mahsa Sedighi, Neha Shrestha, Zahra Mahmoudi, et al.
Polymers (2023) Vol. 15, Iss. 5, pp. 1160-1160
Open Access | Times Cited: 55
Polymeric STING Pro‐agonists for Tumor‐Specific Sonodynamic Immunotherapy
Jie Yu, Shasha He, Chi Zhang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 32
Closed Access | Times Cited: 44
Peptide‐conjugated Nanoparticle Platforms for Targeted Delivery, Imaging, and Biosensing Applications
Bogdan Dragoş Ilieş, İbrahim Yıldız, Muhammad Abbas
ChemBioChem (2024) Vol. 25, Iss. 10
Closed Access | Times Cited: 15
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Yong Xi, Lijie Chen, Jian Tang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 94-114
Closed Access | Times Cited: 38
Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors
Jinseong Kim, Hanhee Cho, Dong-Kwon Lim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10082-10082
Open Access | Times Cited: 31
Application of molecular dynamics simulation in self-assembled cancer nanomedicine
Xueli Xu, Ao Liu, Shuangqing Liu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives
Yunchao Zhang, Chenxin Liu, Chunjie Wu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114257-114257
Open Access | Times Cited: 27
Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives
Hamid Aria, Marzieh Rezaei
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114503-114503
Open Access | Times Cited: 25
Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review
Zaigang Zhou, Haoxiang Wang, Jie Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127911-127911
Closed Access | Times Cited: 22
Precisely Activating cGAS‐STING Pathway with a Novel Peptide‐Based Nanoagonist to Potentiate Immune Checkpoint Blockade Cancer Immunotherapy
Yumeng Xing, Ao Peng, Jianhui Yang, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 13
Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches
Ahmed O. Elzoghby, Omar Samir, Hagar E. S. Emam, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2475-2504
Open Access | Times Cited: 10
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
PD-L1 peptides in cancer immunoimaging and immunotherapy
Shiye Du, Junzhi Liu, Youjia Zhang, et al.
Journal of Controlled Release (2025) Vol. 378, pp. 1061-1079
Closed Access | Times Cited: 1
Cell-Penetrating Peptide Like Anti-Programmed Cell Death-Ligand 1 Peptide Conjugate-Based Self-Assembled Nanoparticles for Immunogenic Photodynamic Therapy
Jun-Hyuck Lee, Seong-Bin Yang, Seong Jin Park, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Functionalized Peptide-Based Nanoparticles for Targeted Cancer Nanotherapeutics: A State-of-the-Art Review
Ritika Sharma, Shikha Jyoti Borah, Bhawna Verma, et al.
ACS Omega (2022) Vol. 7, Iss. 41, pp. 36092-36107
Open Access | Times Cited: 31
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment
Chengliang Sun, Mingxiao Yin, Yao Cheng, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 3, pp. 2064-2083
Closed Access | Times Cited: 28
Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders
Emanuela Senjor, Janko Kos, Milica Perišić Nanut
Biomedicines (2023) Vol. 11, Iss. 2, pp. 476-476
Open Access | Times Cited: 20
RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges
Jong Won Lee, Man Kyu Shim, Hyo‐Suk Kim, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115073-115073
Open Access | Times Cited: 20
Self-reinforced photodynamic immunostimulator to downregulate and block PD-L1 for metastatic breast cancer treatment
Ziwen Qiu, Zhen‐Ming Lu, Jiaqi Huang, et al.
Biomaterials (2023) Vol. 303, pp. 122392-122392
Closed Access | Times Cited: 19
Elucidation of Spatial Cooperativity in Chemo‐Immunotherapy by a Sequential Dual‐pH‐Responsive Drug Delivery System
Shihao Wang, Lifeng Liu, Limin Tian, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 7
Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy
Fengjuan Xie, Shasha Tang, Ye Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 2, pp. 1690-1701
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top